08/05/2019 Researchers studying large genetic datasets identify JAK-STAT signalling as a potential target for AD therapy Science watch
07/05/2019 Actinogen Medical announces results from its Phase II clinical trial XanADu in AD Science watch
07/05/2019 Merck presents positive Phase III data of BELSOMRA® (suvorexant) for the treatment of insomnia in AD Science watch
07/05/2019 Study suggests that spatial navigationability may help identify people at high genetic risk of developing AD Science watch
06/05/2019 Alector announces the recruitment of the first participant in Phase Ib trial of AL002 for AD Science watch
06/05/2019 Researchers link cognitive decline in Parkinson’s disease with genetic variants of AD Science watch
01/05/2019 High-resolution mapping of single brain cells from people with AD identifies early molecular drivers of disease Science watch
11/04/2019 Researchers publish study findings of the halted Phase III AD drug trial on verubecestat Science watch
07/04/2019 Study on mice aims to block gum disease-related bacteria from traveling into the brain to avoid the release of toxins that might be involved in the development of AD Science watch
03/04/2019 Amylyx Pharmaceuticals announces recruitment of first participants in a recently expanded Phase II trial of AMX0035 for AD Science watch
